PROPOVEN

This brand name is authorized in Estonia, Ireland, Lithuania, United Kingdom

Active ingredients

The drug PROPOVEN contains one active pharmaceutical ingredient (API):

1 Propofol
UNII YI7VU623SF - PROPOFOL

Propofol (2, 6-diisopropylphenol) is a short-acting general anaesthetic agent with a rapid onset of action of approximately 30 seconds.

Read about Propofol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PROPOVEN Emulsion for injection/infusion Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N01AX10 Propofol N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AX Other general anesthetics
Discover more medicines within N01AX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1160851, 1160862, 1160873, 1160884, 1160895, 1160907, 1160918, 1160929, 1160930, 1160941, 1160974, 1160985, 1160996, 1538513, 1538524, 1666223, 1666234, 1666302, 1708387, 1736007, 1830686, 1830697
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 365334, 365336, 365338, 366128
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1017504, 1017505, 1017506, 1017508, 1017509, 1017510, 1017511, 1017512, 1017513, 1017514, 1017515, 1017516, 1017517, 1062020, 1062021, 1071838, 1071839, 1077827, 1079494, 1081699, 1090986, 1090987

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.